JP2022511498A5 - - Google Patents
Info
- Publication number
- JP2022511498A5 JP2022511498A5 JP2021531818A JP2021531818A JP2022511498A5 JP 2022511498 A5 JP2022511498 A5 JP 2022511498A5 JP 2021531818 A JP2021531818 A JP 2021531818A JP 2021531818 A JP2021531818 A JP 2021531818A JP 2022511498 A5 JP2022511498 A5 JP 2022511498A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862776323P | 2018-12-06 | 2018-12-06 | |
| US62/776,323 | 2018-12-06 | ||
| PCT/US2019/065005 WO2020118213A1 (en) | 2018-12-06 | 2019-12-06 | Methods for treating cancer resistant to cdk4/6 inhibitors |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022511498A JP2022511498A (ja) | 2022-01-31 |
| JP2022511498A5 true JP2022511498A5 (https=) | 2022-12-19 |
| JPWO2020118213A5 JPWO2020118213A5 (https=) | 2022-12-19 |
| JP7504097B2 JP7504097B2 (ja) | 2024-06-21 |
Family
ID=69063871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531818A Active JP7504097B2 (ja) | 2018-12-06 | 2019-12-06 | Ｃｄｋ４／６阻害剤に耐性の癌を治療するための方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20210330612A1 (https=) |
| EP (1) | EP3890834A1 (https=) |
| JP (1) | JP7504097B2 (https=) |
| KR (1) | KR20210100137A (https=) |
| CN (2) | CN113164779A (https=) |
| AU (1) | AU2019395093B2 (https=) |
| BR (1) | BR112021010110A2 (https=) |
| CA (1) | CA3121930A1 (https=) |
| EA (1) | EA202191283A1 (https=) |
| IL (1) | IL283659A (https=) |
| JO (1) | JOP20210137B1 (https=) |
| MA (1) | MA54388A (https=) |
| MX (1) | MX2021006411A (https=) |
| PH (1) | PH12021551319A1 (https=) |
| SG (1) | SG11202105531XA (https=) |
| UA (1) | UA130036C2 (https=) |
| WO (1) | WO2020118213A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102674902B1 (ko) | 2016-12-01 | 2024-06-14 | 아비나스 오퍼레이션스, 인코포레이티드 | 에스트로겐 수용체 분해제로서의 테트라히드로나프탈렌 및 테트라히드로이소퀴놀린 유도체 |
| IL320609A (en) | 2019-08-26 | 2025-07-01 | Arvinas Operations Inc | Methods for treating breast cancer with a history of tetrahydronaphthalene as estrogen receptor-disrupting agents |
| CN116744925A (zh) * | 2020-12-14 | 2023-09-12 | 阿尔维纳斯运营股份有限公司 | 用四氢萘衍生物作为雌激素受体降解剂治疗乳腺癌的方法 |
| GB202116745D0 (en) * | 2021-11-19 | 2022-01-05 | Institute Of Cancer Res Royal Cancer Hospital | Prognostic and treatment response predictive method |
| CN115369089A (zh) * | 2022-08-11 | 2022-11-22 | 中山大学孙逸仙纪念医院 | 两种er阳性her-2阴性乳腺癌cdk4/6抑制剂耐药株及其构建方法和用途 |
| CN116327894A (zh) * | 2023-04-10 | 2023-06-27 | 上海市第一妇婴保健院 | 一种治疗kras突变的卵巢癌的组合药物及其应用 |
| WO2025202871A1 (en) * | 2024-03-27 | 2025-10-02 | Pfizer Inc. | Methods for identifying biomarkers of treatment response and use thereof with a cdk4 inhibitor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9421264B2 (en) * | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
| JP7019422B2 (ja) * | 2015-04-29 | 2022-02-15 | ラジウス ファーマシューティカルズ，インコーポレイテッド | 癌を治療するための方法 |
| KR102707399B1 (ko) * | 2017-01-05 | 2024-09-13 | 래디어스 파마슈티컬스, 인코포레이티드 | Rad1901-2hcl의 다형 형태 |
| IL279853B2 (en) * | 2018-07-04 | 2025-01-01 | Radius Pharmaceuticals Inc | Polymorphic forms of RAD 1901-2HCL |
-
2019
- 2019-12-06 CN CN201980081052.7A patent/CN113164779A/zh active Pending
- 2019-12-06 MX MX2021006411A patent/MX2021006411A/es unknown
- 2019-12-06 EP EP19829727.7A patent/EP3890834A1/en active Pending
- 2019-12-06 SG SG11202105531XA patent/SG11202105531XA/en unknown
- 2019-12-06 BR BR112021010110-1A patent/BR112021010110A2/pt unknown
- 2019-12-06 KR KR1020217020435A patent/KR20210100137A/ko not_active Ceased
- 2019-12-06 CN CN202411710355.XA patent/CN119548484A/zh active Pending
- 2019-12-06 AU AU2019395093A patent/AU2019395093B2/en active Active
- 2019-12-06 JP JP2021531818A patent/JP7504097B2/ja active Active
- 2019-12-06 MA MA054388A patent/MA54388A/fr unknown
- 2019-12-06 US US17/299,948 patent/US20210330612A1/en not_active Abandoned
- 2019-12-06 UA UAA202103017A patent/UA130036C2/uk unknown
- 2019-12-06 EA EA202191283A patent/EA202191283A1/ru unknown
- 2019-12-06 WO PCT/US2019/065005 patent/WO2020118213A1/en not_active Ceased
- 2019-12-06 CA CA3121930A patent/CA3121930A1/en active Pending
- 2019-12-06 PH PH1/2021/551319A patent/PH12021551319A1/en unknown
-
2021
- 2021-06-02 IL IL283659A patent/IL283659A/en unknown
- 2021-06-06 JO JOJO/P/2021/0137A patent/JOP20210137B1/ar active
-
2025
- 2025-06-26 US US19/250,779 patent/US20250319044A1/en active Pending